MNMD Stock Analysis: Buy, Sell, or Hold?
MNMD - Mind Medicine (MindMed) Inc. Common Shares
$15.02
0.15 (1.01%)
▲
BUY
MODERATE Confidence
Last Updated: January 14, 2026
Earnings: Mar 05, 2026
Get Alerted When MNMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MNMD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MNMD shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: MNMD shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MNMD is currently trading at $15.02, which is considered extended relative to its 30-day fair value range of $13.22 to $14.42.
Technical Outlook: Technically, MNMD is in a strong uptrend. The price is approaching resistance at $15.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MNMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.67 (+90.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MNMD is in a strong uptrend. The price is approaching resistance at $15.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MNMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.67 (+90.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$13.22 -
$14.42
Company Quality Score
62/100
(BUY)
Options IV Signal
65th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
64.6%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 65th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 90.9% below Wall St target ($28.67)
Fair Price Analysis
30-Day Fair Range
$13.22 -
$14.42
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$2.77
(18.4%)
Support & Resistance Levels
Support Level
$12.88
Resistance Level
$15.29
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-8.47
Wall Street Target
$28.67
(+90.9%)
Last updated: January 31, 2026 12:58 PM ET
Data refreshes hourly during market hours. Next update: 1:58 PM
Data refreshes hourly during market hours. Next update: 1:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Daniel Karlin
SELL
7704 shares
2025-09-25
Mark Sullivan
SELL
11278 shares
2025-09-25
Robert Barrow
SELL
25797 shares
2025-09-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced MNMD Option Strategies
Professional options setups generated by AI based on today's MNMD price and gamma walls.
